Literature DB >> 6779945

Lipoatrophy and monocomponent porcine insulin.

G R Jones, B Statham, D R Owens, M K Jones, T M Hayes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6779945      PMCID: PMC1503934          DOI: 10.1136/bmj.282.6259.190

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  2 in total

1.  Very pure porcine insulin in clinical practice.

Authors:  A D Wright; C H Walsh; M G Fitzgerald; J M Malins
Journal:  Br Med J       Date:  1979-01-06

2.  Insulin-induced lipoatrophy: evidence for an immune pathogenesis.

Authors:  W G Reeves; B R Allen; R B Tattersall
Journal:  Br Med J       Date:  1980-06-21
  2 in total
  7 in total

Review 1.  The skin in diabetes mellitus.

Authors:  M J Goodfield; L G Millard
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

2.  Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.

Authors:  P G McNally; N I Jowett; J J Kurinczuk; R W Peck; J R Hearnshaw
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

3.  Paradoxical lipodystrophic changes due to conventional bovine and highly purified porcine/bovine insulins.

Authors:  I W Campbell; C Duncan; A R Anani
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

4.  Lipoatrophy in a patient on highly purified beef insulin.

Authors:  L G Evans-Jones
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

5.  Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.

Authors:  A Czyzyk; H Rogala; J Lawecki
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

6.  Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.

Authors:  R M Wilson; C A Douglas; R B Tattersall; W G Reeves
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

Review 7.  The new insulins. Their characteristics and clinical indications.

Authors:  P D Home; K G Alberti
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.